Study for Patients with Colorectal Cancer or Colorectal Lesion

Clinical Trial Title

Blood and stool sample collection in subjects with a diagnosis of colorectal cancer or colorectal lesion.

National Clinical Trial Number:

NCT03789162

Clinical Trial Protocol Description:

Enrolled subjects will provide a blood and stool sample at least 7 days after pre-enrollment colonoscopy but prior to bowel preparation for follow-up procedure (i.e. surgery, neoadjuvant chemotherapy, radiation therapy, and/or therapeutic colonoscopy).

Clinical Trial Eligibility Criteria:

In order to participate you must meet the following criteria:

  • Are male or female, 40 years of age or older.
  • Have a diagnosis of CRC, at any stage, confirmed with a tissue biopsy or a colorectal lesion at least 1 cm in size suspicious for adenoma (including sessile serrated adenoma) or CRC on a pre-enrollment colonoscopy.
  • Post-colonoscopy, the residual lesion in the colon must be at least 1 cm in size as to require additional surgical excision or complex colonoscopic polypectomy.
  • Understand the study procedures and are able to provide informed consent to participate in the study and authorization for release of relevant protected health information to the study Investigator.

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Study Details

Clinical Trial Investigator

Joshua Melson, MD

Contact Information

Rush Cancer Center Clinical Trials Office